MRPI - Mera Pharmaceuticals, Inc.

Mera Pharmaceuticals, Inc.

8275 S. Easter Avenue
Suite 200
Las Vegas, NV 89123
United States
604 500 4157

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Benny Doro	CEO, Interim Director, Pres & Sec.	N/A	N/A	1968
Mr. Lawrence Harris Wolfe	Chief Financial Officer, VP of Fin. and Director	N/A	N/A	1963
Ms. Melanie K. Kelekolio	Gen. Mang. of The Operations & Production Facility and VP	N/A	N/A	1968
Ms. Joyce Markley	Sec. and Director	N/A	N/A	1952
Mr. Rafi Markarians	Treasurer & Director	N/A	N/A	1966

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Mera Pharmaceuticals, Inc. focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology. The company is also involved in the development of sea salt; and operation of family entertainment center focused on promoting health and wellness through the Villari's system of martial arts. In addition, it provides food production and delivery services. Mera Pharmaceuticals, Inc. was founded in 1983 and is based in Las Vegas, Nevada.

Corporate Governance

Mera Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.